W19
Active

Endpoint Health

Targeted therapies for critical care

The first targeted therapeutics company focused on integrated solutions for critical illnesses, Endpoint Health combines novel and on-market therapeutics, companion diagnostics, and artificial intelligence into an integrated platform designed to improve outcomes in critically ill patients.

Endpoint Health
Founded2018
Team Size15
LocationPalo Alto

Diego Rey, CSO

Diego is currently co-founder, board member, and Chief Scientific Officer of Endpoint Health a targeted therapeutics company in critical care. Prior to Endpoint, Diego co-founded GeneWEAVE, a diagnostics company that develops diagnostic products for detecting infections and guiding antibiotic therapy. Started in 2010, GeneWEAVE raised $25M in venture financing and was acquired by Roche in 2015 for $425M. Diego is also a former visiting partner and currently an bio Expert at YC.

Jeff Osborn

Jeff Osborn
Endpoint Health

Jason Springs

Jason Springs
Endpoint Health

Leonardo Teixeira

Leonardo Teixeira
Endpoint Health